Bibliography
- Yamamoto S, Aizu E, Jiang H, The potent anti-tumor promoting agent isoliquiritigenin. Carcinogenesis 1991;12(2):317-23
- Kanazawa M, Satomi Y, Mizutani Y, Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 2003;43(5):580-6
- Kwon GT, Cho HJ, Chung WY, Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 2009;20(9):663-76
- Auyeung KK, Ko JK. Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell. Invest New Drugs 2010;28(1):1-13
- Yadav VR, Prasad S, Sung B, Aggarwal BB. The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer. Int Immunopharmacol 2011;11(3):295-309
- Chen X, Wu Y, Jiang Y, Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. J Mol Med (Berl) 2012;90(11):1311-19
- Maggiolini M, Statti G, Vivacqua A, Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 2002;82(4-5):315-22
- Ye L, Gho WM, Chan FL, Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overespressing aromatase. Int J Can 2009;124:1028-36
- Lau GT, Ye L, Leung LK. The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. Planta Med 2010;76(8):780-5
- Wang KL, Hsia SM, Chan CJ, Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells. Expert Opin Ther Targets 2013;17(4):337-49